MAPT and Alzheimer disease: These results suggest that WERG-H treatment can ameliorate intestinal metabolic disturbances by increasing the abundance of probiotics, thereby exerting anti-AD effects by remodeling the gut microbiota and reducing p-tau levels (Figure 8).